Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Potent and selective DAT ligand identified by RTI and Emory University

Jan. 22, 1999

Novel pure mu/kappa-opioid receptor antagonist as a lead in the field of drug abuse therapy

Jan. 20, 1999

Orphan drug for iron overload offered for licensing by Biomedical Frontiers

Jan. 18, 1999

Generic smoking cessation aid receives tentative FDA approval

Jan. 13, 1999

Novel cocaine analogues with promise in the treatment of cocaine addiction or overdose

Jan. 8, 1999

FDA approves OTC status for Elan's nicotine patch

Jan. 7, 1999

Selective inhibitor of neuronal dopamine transporter developed by U.S. university team

Jan. 4, 1999

Lilly develops novel 5-HT1A/5-HT1D antagonists for smoking cessation and CNS disorders

Dec. 23, 1998

SB launches smoking cessation line in European markets

Dec. 1, 1998

U.S. university researchers claim cocaine analogues for drug addiction, PD and depression

Nov. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...